THROMBOSIS RESEARCH INSTITUTE

USPTO USPTO 2004 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke THROMBOSIS RESEARCH INSTITUTE wurde als Wortmarke am 09.04.2004 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 23.08.2005 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 08. August 2019

Markenform Wortmarke
Aktenzeichen 76586055
Registernummer 2988319
Anmeldedatum 09. April 2004
Eintragungsdatum 23. August 2005

Markeninhaber

Manresa Road
Chelsea, London SW3 6LR
GB

Markenvertreter

Waren und Dienstleistungen

16 PUBLICATIONS AND DOCUMENTS, NAMELY, PAMPHLETS, BOOKLETS, PRINTED LECTURES, SCIENTIFIC REPORTS AND NEWSLETTERS, IN THE FIELDS OF BIOLOGY, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY AND/OR PROTEOLYSIS, VASCULAR DISORDERS, THROMBOTIC DISORDERS, ARTHEROSCLEROSIS, HAEMOSTASIS, HYPERCOAGULABILITY, PHARMACEUTICALS, CANDIDATE PHARMACEUTICAL PRODUCTS, MEDICINE, MOLECULAR BIOLOGY, CHEMISTRY AND DISEASE
41 EDUCATIONAL SERVICES, NAMELY PROVIDING AND CONDUCTING PROGRAMS, TRAINING, TEACHING, LECTURING, AND ARRANGING AND/OR CONDUCTING OF COLLOQUIUMS, SEMINARS, SYMPOSIUMS AND/OR WORKSHOPS, ALL IN THE FIELDS OF BIOLOGY, MEDICINE, PHARMACEUTICALS, THROMBOSIS AND ATHEROSCLEROSIS AND/OR THE BIOLOGY OR TREATMENT THEREOF; PROVISION OF INFORMATION RELATING TO BIOLOGY, MEDICINE, PHARMACEUTICALS, THROMBOSIS AND ATHEROSCLEROSIS AND/OR THE BIOLOGY OR TREATMENT THEREOF
42 MEDICAL RESEARCH; SCIENTIFIC RESEARCH; MEDICAL AND SCIENTIFIC RESEARCH IN THE FIELD OF BIOLOGY, MEDICINE, PHARMACEUTICALS, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY, PROTEOLYSIS, THROMBOSIS, ATHEROSCLEROSIS, AND/OR THE BIOLOGY OR TREATMENT THEREOF; RESEARCH AND DEVELOPMENT SERVICES TO FIND AND DEVELOP NEW PHARMACEUTICAL PRODUCTS FOR OTHERS TO PUT ON THE MARKET; THE PROVISION OF REPORTS AND INFORMATION RELATING TO CHEMICALS, BIOLOGICAL PRODUCTS, THE PREPARATION OF EITHER, FORMULATIONS, CANDIDATE PHARMACEUTICAL PRODUCTS, PHARMACEUTICAL RESEARCH PROJECTS, PHARMACEUTICAL RESEARCH SERVICES, MEDICINE, CHEMISTRY, MOLECULAR BIOLOGY, AND DISEASE; ARRANGING INVESTIGATIONS AND RESEARCH IN THE FIELD OF PHARMACEUTICALS TO OBTAIN INFORMATION AND DATA, TO BE SUPPLIED TO OTHERS, RELATING TO DRUGS, FORMULATIONS AND CANDIDATE PHARMACEUTICAL PRODUCTS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES; ARRANGING AND CONDUCTING MEDICAL AND SCIENTIFIC RESEARCH; PREPARING OR ARRANGING THE PREPARATION OF CHEMICALS, BIOLOGICAL PRODUCTS, FORMULATIONS AND/OR CANDIDATE PHARMACEUTICAL PRODUCTS FOR RESEARCH AND TESTING BY OTHERS; PROVIDING INFORMATION IN THE FIELD OF BIOLOGY, MEDICINE, PHARMACEUTICALS, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY, PROTEOLYSIS, THROMBOSIS, ATHEROSCLEROSIS, AND/OR THE BIOLOGY OR TREATMENT THEREOF, PHARMACEUTICAL DRUG DEVELOPMENT, CLINICAL TRIALS, MEDICAL AND SCIENTIFIC RESEARCH, THE PREPARATION OF CHEMICALS, BIOLOGICAL PRODUCTS, FORMULATIONS AND/OR CANDIDATE PHARMACEUTICAL PRODUCTS FOR RESEARCH AND TESTING; PROMOTING PUBLIC AWARENESS FOR THE NEED FOR THROMBOSIS AND ATHEROSCLEROSIS TESTING AND TREATMENT, AND RESEARCH ON THE TESTING AND TREATMENT FOR THROMBOSIS AND ATHEROSCLEROSIS; PROVIDING REPORTS AND INFORMATION RELATING TO INTELLECTUAL PROPERTY RIGHTS
44 MEDICAL SERVICES; MEDICAL TESTING
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1376586055